Skip to main content

Diabetes and Metabolism

The Diabetes and Metabolism Research Group is search is lead by Dr. Rafael Simó (Hirsch index:54), Head of the Endocrinology Department, Professor of Medicine & Endocrinology at UAB and current President of the European Association for the Study of Diabetes-Eye Complications. The group consists of 7 senior clinical investigators, 4 basic post-doctoral researchers, 4 pre-doc researchers, 3 laboratory technicians and one coordinator of clinical assays.  

The group belongs to “CIBER” of Diabetes and Associated Metabolic Diseases (CIBERDEM. ISCIII) and has been recognized as consolidated group by the Generalitat de Catalunya (AQU/AGAUR).

Since 2014 this group has been qualified as outstanding in the evaluations performed by the ANEP, CIBERDEM and the external Scientific Advisory Board of VHIR. 

The main lines of research are:

  • Complications of diabetes (in particular diabetic retinopathy)
  • Obesity and its co-morbidities
  • Type 2 diabetes and cognitive impairment
  • Thyroid diseases
  • Hospital Nutrition. 

Team

Daniel Perez Martinez

Daniel Perez Martinez

Predoctoral researcher
Diabetes and Metabolism
Read more
David Zornoza Motilla

David Zornoza Motilla

Research technician
Diabetes and Metabolism
Read more
Fiorella Ximena Palmas Candia

Fiorella Ximena Palmas Candia

Research technician
Diabetes and Metabolism
Read more
Hernández Baixauli, Júlia

Hernández Baixauli, Júlia

Main researcher
Diabetes and Metabolism
Read more
Hugo Ramos Abellan

Hugo Ramos Abellan

Research technician
Diabetes and Metabolism
Read more
Laia Queralt Mercadé

Laia Queralt Mercadé

Research technician
Diabetes and Metabolism
Read more
Daniel Perez Martinez

Daniel Perez Martinez

Predoctoral researcher
Diabetes and Metabolism
Read more
David Zornoza Motilla

David Zornoza Motilla

Research technician
Diabetes and Metabolism
Read more
Fiorella Ximena Palmas Candia

Fiorella Ximena Palmas Candia

Research technician
Diabetes and Metabolism
Read more
Hernández Baixauli, Júlia

Hernández Baixauli, Júlia

Main researcher
Diabetes and Metabolism
Read more
Hugo Ramos Abellan

Hugo Ramos Abellan

Research technician
Diabetes and Metabolism
Read more
Laia Queralt Mercadé

Laia Queralt Mercadé

Research technician
Diabetes and Metabolism
Read more

Projects

Metabolisme

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 160000
Reference: SIMO/BOOST/2024
Duration: 15/11/2024 - 14/11/2028

CARACTERIZACIÓN HISTOLÓGICA DE LOS NÓDULOS TIROIDEOS CON CITOLOGÍA INDETERMINADA (BETHESDA IV) MEDIANTE EL ANÁLISIS CON TÉCNICAS DE APRENDIZAJE AUTOMÁTICO BASADAS EN TRANSFER LEARNING DE IMÁGENES CITOLÓGICAS

IP: Carles Zafon Llopis
Collaborators: Jordi Temprana Salvador, Carmela Iglesias i Felip
Funding agency: Fundación Sdad Española Endocrinologia y Nutrición
Funding: 10000
Reference: SEEN/PROJECTE/ZAFON/2024
Duration: 01/01/2025 - 01/01/2026

¿CONOCER LA PREDISPOSICIÓN GENETICA DEL PACIENTE CON OBESIDAD AYUDA A MEJORAR LA EFICACIA DE LA CIRUGÍA BARIÁTRICA?

IP: Albert Lecube Torelló
Collaborators: Marta Comas Martinez, Enzamaría Fidilio Meli
Funding agency: Instituto de Salud Carlos III
Funding: 117370
Reference: PI21/00462
Duration: 01/01/2022 - 30/06/2026

Resistencia a la insulina en la diabetes tipo 2: clarificando el mecanismo patogénico de la resistencia a la insulina miocárdica y los efectos de tratamientos con GLP-1 RA y SGLT2i

IP: José Raul Herance Camacho
Collaborators: Sofia Rodriguez Fernandez, Sergi Velasco Vila, Clara Ramírez Serra, Azahara Maria Palomar Muñoz, Cristina Gamez Cenzano, Jana Vidal Otero, Carolina Aparicio Gomez, Alberto Roque Pérez, Mercè Abad Martín, Olga Simó Servat, Pedro Alejandro Gil Millán, Emily Betancourt Fernández, Martha Sahylí Ortega Pijeira, Maria Nazarena Pizzi, Enrique Franky Vargas
Funding agency: Instituto de Salud Carlos III
Funding: 252500
Reference: PI24/01356
Duration: 01/01/2025 - 31/12/2027

Blog

News

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.